India Pemetrexed Market Size & Outlook, 2025-2033


India Pemetrexed Market Insights

  • Reed Intelligence analysis indicates that the India Pemetrexed Market size, valued at USD 81.8 Million in 2024, is expected to expand to USD 95.04 Million by 2033.
  • The India market is forecasted to expand at a CAGR of 1.67% spanning 2026–2033.
  • Malignant Pleural Mesothelioma held the leading position among By Application segments in 2024, based on market size.
  • Malignant Pleural Mesothelioma is projected to post the fastest growth rate, sustaining its position as the most attractive By Application segment during the forecast horizon.

Other Key Findings


  • In 2024, India accounted for 3.5% of the global Pemetrexed Market size.
  • By 2033, United States is expected to lead the global Pemetrexed Market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional Pemetrexed Market size by 2033.
  • India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 94.95 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 81.8 Million
Market Size In 2033 USD 95.04 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.67% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends